Raptor Pharmaceutical Corp (RPTP)

9.00
0.00 (0.00)
NASDAQ : Health Care
Prev Close 9.00
Open 8.95
Day Low/High 8.95 / 9.05
52 Wk Low/High 2.94 / 14.90
Volume 753.41K
Avg Volume 2.45M
Exchange NASDAQ
Shares Outstanding 85.31M
Market Cap 767.76M
EPS -0.80
P/E Ratio N/A
Div & Yield N.A. (N.A)
Interesting RPTP Put And Call Options For July 19th

Interesting RPTP Put And Call Options For July 19th

Investors in Raptor Pharmaceuticals Corp. saw new options become available this week, for the July 19th expiration.

3 Stocks Under $10 Moving Higher

3 Stocks Under $10 Moving Higher

When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

4 Stocks Under $10 Moving Higher

4 Stocks Under $10 Moving Higher

When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

First Week Of November 22nd Options Trading For Raptor Pharmaceuticals (RPTP)

First Week Of November 22nd Options Trading For Raptor Pharmaceuticals (RPTP)

Investors in Raptor Pharmaceuticals Corp. saw new options become available this week, for the November 22nd expiration.

These Stocks Are Getting Hit Hardest During March's Biotech 'Correction'

These Stocks Are Getting Hit Hardest During March's Biotech 'Correction'

Geron, Celldex Therapeutics, Xoma and Cytrx are among the drug stocks losing more than 30% of their value in the past month.

Relative Strength Alert For Raptor Pharmaceuticals

Relative Strength Alert For Raptor Pharmaceuticals

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

First Week of April 19th Options Trading For Raptor Pharmaceuticals (RPTP)

First Week of April 19th Options Trading For Raptor Pharmaceuticals (RPTP)

Investors in Raptor Pharmaceuticals Corp. saw new options become available this week, for the April 19th expiration.

Biotech Stock Mailbag: Raptor, Chelsea, Oncogenex, More Hate Mail!

Biotech Stock Mailbag: Raptor, Chelsea, Oncogenex, More Hate Mail!

Biotech columnist Adam Feuerstein answers readers' questions about health care companies.

Jim Cramer's 'Mad Money' Recap: Next Week's Game Plan

Jim Cramer's 'Mad Money' Recap: Next Week's Game Plan

The futures have a way of taking down the entire market for no particular reason, and it's times like those when investors should be buying, Cramer says.

22 Biotech Stock Predictions for 2014

22 Biotech Stock Predictions for 2014

TheStreet's Adam Feuerstein offers his biotech stock outlook for 2014 and grades his 2013 predictions.

Interesting RPTP Call Options For August 2014

Interesting RPTP Call Options For August 2014

Investors in Raptor Pharmaceuticals Corp. saw new options begin trading today, for the August 2014 expiration.

Raptor Submits IND For RP103 For Leigh Syndrome And Other Mitochondrial Disorders

Raptor Submits IND For RP103 For Leigh Syndrome And Other Mitochondrial Disorders

Trial Anticipated to Begin Enrolling in Q1 2014

First Week Of January 2014 Options Trading For Raptor Pharmaceuticals (RPTP)

First Week Of January 2014 Options Trading For Raptor Pharmaceuticals (RPTP)

Investors in Raptor Pharmaceuticals Corp. saw new options become available this week, for the January 2014 expiration.

Raptor Pharmaceutical Corp. Provides PROCYSBI(R) Launch Update And Third Quarter 2013 Financial Results

Raptor Pharmaceutical Corp. Provides PROCYSBI(R) Launch Update And Third Quarter 2013 Financial Results

First Quarter Following Launch Confirms Anticipated Strong PROCYSBI Uptake

5 Stocks Poised to Break Out

5 Stocks Poised to Break Out

These stocks look ready to break out and trade higher from current levels.

First Week Of May 2014 Options Trading For Raptor Pharmaceuticals (RPTP)

First Week Of May 2014 Options Trading For Raptor Pharmaceuticals (RPTP)

Investors in Raptor Pharmaceuticals Corp. saw new options become available this week, for the May 2014 expiration.

'Mad Money' Lightning Round: Primerica's a Long-Term Play

'Mad Money' Lightning Round: Primerica's a Long-Term Play

Avanir Pharmaceuticals is a great speculative biotech, Cramer said, but he's worried about DaVita.

Cramer's 'Mad Money' Recap: China and U.S. Stocks

Cramer's 'Mad Money' Recap: China and U.S. Stocks

After years of dragging U.S. stocks lower, a turn is at hand overseas, Cramer said.